Previous 10 | Next 10 |
VANCOUVER, Wash., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced it will be participating virtually in the following ...
VANCOUVER, Wash., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the opening of its new campus located in Vancouver, ...
VANCOUVER, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced it will report financial results for the third quart...
Absci’s AI-powered discovery and development platform to further expand EQRx’s portfolio of innovative, affordable medicines EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower...
VANCOUVER, Wash., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upc...
Coinbase (NASDAQ:COIN) represented one of the biggest topics of conversation on Wall Street during midday action on Wednesday. Shares dipped following a dispute with regulators over its Lend product. PayPal (NASDAQ:PYPL) also took its share of the spotlight. A multi-billion purchase weighed o...
Gainers: Kadmon (NASDAQ:KDMN) +73%. ICU Medical (NASDAQ:ICUI) +32%. Candel Therapeutics (NASDAQ:CADL) +23%. Globalstar (NYSE:GSAT) +22%. Spectrum Brands (NYSE:SPB) +20%. Vinco Ventures (NASDAQ:BBIG) +19%. WISeKey (NASDAQ:WKEY) +14%. SilverBow (NYSE:SBOW) +16%. Aterian (NASDAQ:ATER) +16%. Gain...
VANCOUVER, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter ended J...
Gainers: Globalstar (NYSE:GSAT) +61%. Vinco Ventures (NASDAQ:BBIG) +50%. Affirm (NASDAQ:AFRM) +43%. Support (NASDAQ:SPRT) +41%. Katapult (NASDAQ:KPLT) +38%. ATIF (NASDAQ:ATIF) +34%. Sphere 3D (NASDAQ:ANY) +30%. WISeKey (NASDAQ:WKEY) +21%. Empresa Distribuidora Comercializadora Norte (NY...
Gainers: SmileDirectClub (NASDAQ:SDC) +14%, Voyager Therapeutics (NASDAQ:VYGR) +13%, Owlet (NYSE:OWLT) +12%, Ontrak (NASDAQ:OTRK) +10%, Evaxion Biotech (NASDAQ:EVAX) +9%. Losers: 22nd Century XXII -15%, Absci (NASDAQ:ABSI) -12%, NeuroMetr...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, Wash. and NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will report business updates and financial and operating results for the second quarter after market close on Wednesday,...
VANCOUVER, Wash. and NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced that on July 1, 2024, the company granted a non-statutory stock option to purchase an aggregate of 613,000 shares of its common stoc...
VANCOUVER, Wash. and NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Morgan Stanley 3 rd Annual Life Sciences AI Summit on June 26-27 in New York, ...